S&P 500, Dow end session flat, tech boosts Nasdaq

The TJX Companies (TJX) PT Lowered to $84 at Instinet

Instinet lowered its price target on The TJX Companies (NYSE: TJX) to $84.00 (from $87.00) while maintaining a Buy rating. TJXs comp was again primarily traffic-driven, with management noting this as the 10th such Q in a row. GM expanded 20bps, driven by gains related... More

Home Depot (HD) PT Raised to $165 at Barclays; Reiterates Overweight

Barclays raised its price target on Home Depot (NYSE: HD) to $165.00 (from $150.00) while maintaining a Overweight rating. Barclays... More

Home Depot (HD) PT Raised to $175 at Baird Following 1Q

Baird raised its price target on Home Depot (NYSE: HD) to $175.00 (from $165.00) while maintaining a Outperform rating. EPS of $1.67 exceeded the Street's $1.61 estimate. Upside was primarily driven by stronger sales and associated opex leverage. 1Q comps increased +5.5% driven by robust big-ticket... More

Home Depot (HD) PT Raised to $165 at Wedbush; Reiterates Neutral

Wedbush raised its price target on Home Depot (NYSE: HD) to $165.00 (from $155.00) while maintaining a Neutral rating. HD reported a solid 5.5% comp, beating the consensus estimate of 4.4%.

HD continues to harness the tailwinds of a housing market and execute at the... More

Home Depot (HD) PT Raised to $179 at Citi; Reiterates Buy

Citi raised its price target on Home Depot (NYSE: HD) to $179.00 (from $168.00) while maintaining a Buy rating.

HD reported a surprise upside off of a stronger than expected comp and reported e-comm growth of 23% y/y. The overall comp was a slight deceleration from Q4 but e-commerce accelerated 400 bps.

Akebia Therapeutics (AKBA) PT Raised to $21 at Needham & Company

Needham & Company raised its price target on Akebia Therapeutics (NASDAQ: AKBA) to $21.00 (from $18.00) while maintaining a Buy rating. Akebia is licensing vadadustat distribution rights to Vifor Pharma for exclusive sale to Fresnius Medical Care. The deal will rapidly give vadadustat access to 40% of the... More

BTIG Reiterates Buy Rating and $175 PT on Home Depot (HD); '1Q EPS Beats Our Above-Street Estimate on Strong Comp, Raises 2017 EPS Guidance'

BTIG reiterates Buy rating and $175 price target on Home Depot (NYSE: HD) following the company's first quarter earnings report.

Analyst Alan Rifkin notes the company produced first quarter earnings per share and revenues above the Street's consensus, while management raised full year 2017 to $7.15 from... More